Kelsen DP - Search Results

1

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

Hu ZI, Shia J, Stadler ZK, Varghese AM, Capanu M, Salo-Mullen E, Lowery MA, Diaz LA Jr, Mandelker D, Yu KH, Zervoudakis A, Kelsen DP, Iacobuzio-Donahue CA, Klimstra DS, Saltz LB, Sahin IH, O'Reilly EM. Hu ZI, et al. Among authors: kelsen dp. Clin Cancer Res. 2018 Mar 15;24(6):1326-1336. doi: 10.1158/1078-0432.CCR-17-3099. Epub 2018 Jan 24. Clin Cancer Res. 2018. PMID: 29367431 Free PMC article.

2

Combined-modality therapy in the treatment of local-regional esophageal cancer.

Saltz L, Kelsen D. Saltz L, et al. Ann Oncol. 1992 Dec;3(10):793-9. doi: 10.1093/oxfordjournals.annonc.a058098. Ann Oncol. 1992. PMID: 1286042 Free article. Review. No abstract available.

3

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

4

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D, Saltz L, Markman M. Rusch VW, et al. J Clin Oncol. 1992 Jun;10(6):1001-6. doi: 10.1200/JCO.1992.10.6.1001. J Clin Oncol. 1992. PMID: 1588364

5

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. J Clin Oncol. 1992 Aug;10(8):1218-24. doi: 10.1200/JCO.1992.10.8.1218. J Clin Oncol. 1992. PMID: 1634912 Clinical Trial.

6

Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.

Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Riechman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. Int J Radiat Oncol Biol Phys. 1992;22(1):139-45. doi: 10.1016/0360-3016(92)90993-r. Int J Radiat Oncol Biol Phys. 1992. PMID: 1727111 Clinical Trial.

7

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. J Clin Oncol. 1992 Jan;10(1):79-84. doi: 10.1200/JCO.1992.10.1.79. J Clin Oncol. 1992. PMID: 1727928

8

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.

Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C. Kelsen D, et al. J Clin Oncol. 1992 Feb;10(2):269-74. doi: 10.1200/JCO.1992.10.2.269. J Clin Oncol. 1992. PMID: 1732428 Clinical Trial.

9

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.

Kelsen D, Hudis C, Niedzwiecki D, Dougherty J, Casper E, Botet J, Vinciguerra V, Rosenbluth R. Kelsen D, et al. Cancer. 1991 Sep 1;68(5):965-9. doi: 10.1002/1097-0142(19910901)68:5<965::aid-cncr2820680509>3.0.co;2-2. Cancer. 1991. PMID: 1833042 Clinical Trial.

10

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.

Crown J, Casper ES, Botet J, Murray P, Kelsen DP. Crown J, et al. Among authors: kelsen dp. J Clin Oncol. 1991 Sep;9(9):1682-6. doi: 10.1200/JCO.1991.9.9.1682. J Clin Oncol. 1991. PMID: 1875224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters